Best in Biotech 22 Jan 2025 Curing ALS? Sixteen companies developing new treatments in 2025 …specializing in the discovery and development of naturally occurring therapeutic antibodies. Its approach focuses on identifying antibodies from individuals who exhibit resilience to certain diseases, aiming to harness these natural… January 22, 2025 - 18 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 19 Jan 2024 Re-coding the brain: Is CRISPR capable of curing neurodegenerative diseases? …also become a vital tool in treating neurodegenerative diseases? Neurodegenerative diseases are tremendously difficult to treat. As Cem Zorlular, chief executive officer (CEO) of Er-Kim Pharmaceuticals pointed out, the brain… January 19, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 12 Oct 2023 Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated? …metabolic changes in immune cells can drive the development of diseases like autoimmune conditions and even cancer, intervening in cell metabolism can potentially reverse inflammation and cure diseases. Immunometabolism is… October 12, 2023 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Oct 2025 Biotech in Luxembourg: five companies that have made their name …degeneration (AMD) and uveitis. Meanwhile, Mitotech’s focus has since expanded to metabolic diseases and neurodegenerative diseases. The company has created a small molecule to treat obesity and metabolic dysfunction-associated steatohepatitis… October 15, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
More News! 7 Nov 2025 Top biotech deals in October 2025 …oncology, and metabolic diseases. The startup will bag $7 million upfront, and it can gain more than $200 million in milestone payments. This means that the deal value could cross a billion dollars if… November 7, 2025 - 13 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Dec 2023 Seven companies shaping the future of precision medicine Precision medicine is an approach to tailoring treatments based on people’s genetic makeup, lifestyles and environment. These targeted interventions can tackle diseases like cancer, neurological as well as metabolic diseases…. December 14, 2023 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 6 Oct 2022 15 biotech companies shaking up the scene in Cambridge …into any other cell type. The company generates functional cell types to address diseases with high unmet clinical need, which includes indications in ophthalmology, metabolic diseases and degenerative disorders. In… October 6, 2022 - 9 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Interview 28 Nov 2018 Navigating the Rare Disease Space: Insights from a Danish CEO …developing treatments for these diseases is getting more feasible. Hinsby said the general opinion that rare diseases are not worth the effort has changed in recent years. “There is a… November 28, 2018 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 7 Apr 2025 Will tRNA therapy be the next big thing in genetic disease treatment? …genetic diseases But how exactly does tRNA play a role in treating diseases? Since their initial description in 1958, tRNAs have largely been viewed as intermediaries in the translation of… April 7, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 1 Jun 2023 Fighting obesity with gene therapy …apply the ex vivo gene therapy technique to generate and implant cells that express the CPT1AM protein, an enzyme that plays a decisive role in many metabolic diseases such as… June 1, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Oct 2024 12 biotech unicorns revolutionizing the future of healthcare …metabolic dysfunction-associated steatotic liver disease (MASLD), based on targets identified by insitro using its AI-based platform. In addition to metabolic diseases, the biotech unicorn is also working in neurodegeneration and… October 10, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Dec 2023 Five companies racing to bring their NASH treatments toward the finish line …in San Francisco, 89bio is on a mission to develop and deliver innovative therapies to treat patients with liver and cardiometabolic diseases. Its lead candidate is called pegozafermin, and is… December 21, 2023 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email